Literature DB >> 12461618

Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy.

Josep Lloreta1, Pere Domingo, Ramón M Pujol, Juan A Arroyo, Núria Baixeras, Xavier Matias-Guiu, Montserrat Gilaberte, Maria A Sambeat, Sergi Serrano.   

Abstract

Chronic treatment with highly active antiretroviral therapy (HAART) results in a novel variety of partial lipodystrophy, combining lipoatrophic and hypertrophic areas. We have previously reported the histopathological features of this disease and have also shown that adipocyte apoptosis is involved in its origin. With the aim of further elucidating the mechanisms underlying this peculiar disorder, we performed an ultrastructural study of the adipocytes of ten HIV-1-infected patients treated with HAART for 20-42 months. In all ten cases, two main sets of ultrastructural changes were identified. Some adipocytes showed disruption of cell membranes, fragmented cytoplasmic rims, irregular cell outlines, and eventually fat droplets laying free in the connective tissue, with a histiocytic reaction around them. In addition, many adipocytes showed variable compartmentalization of fat droplets with decrease in cell size and abundant, mitochondria-rich cytoplasm. Often, a dual "white and brown" fat appearance was observed with a large unilocular vacuole surrounded by a rim of multilocular cytoplasm containing smaller isometric fat droplets and numerous mitochondria. These findings suggest that HAART-associated partial lipodystrophy is probably the result of a remodeling process of fat cells involving variable combinations of apoptosis, defective lipogenesis, and increased metabolic activity in different adipose areas of the body.

Entities:  

Mesh:

Year:  2002        PMID: 12461618     DOI: 10.1007/s00428-002-0667-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  6 in total

1.  Thymidine analogues suppress autophagy and adipogenesis in cultured adipocytes.

Authors:  Metodi V Stankov; Diana Panayotova-Dimitrova; Martin Leverkus; Reinhold E Schmidt; Georg M N Behrens
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

2.  Effects of lifestyle modification and metformin on irisin and FGF21 among HIV-infected subjects with the metabolic syndrome.

Authors:  Suman Srinivasa; Kimberly Wong; Kathleen V Fitch; Jeffrey Wei; Eva Petrow; Aaron M Cypess; Martin Torriani; Steven K Grinspoon
Journal:  Clin Endocrinol (Oxf)       Date:  2014-10-08       Impact factor: 3.478

3.  Mitochondrial DNA content, an inaccurate biomarker of mitochondrial alteration in human immunodeficiency virus-related lipodystrophy.

Authors:  Min Ji Kim; Claude Jardel; Cyrille Barthélémy; Véronique Jan; Jean Philippe Bastard; Sandrine Fillaut-Chapin; Sydney Houry; Jacqueline Capeau; Anne Lombès
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

4.  Differential contribution of chronic binge alcohol and antiretroviral therapy to metabolic dysregulation in SIV-infected male macaques.

Authors:  Stephen M Ford; Liz Simon Peter; Paul Berner; Garth Cook; Curtis Vande Stouwe; Jason Dufour; Gregory Bagby; Steve Nelson; Patricia E Molina
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-07-24       Impact factor: 4.310

5.  Comparison of dorsocervical with abdominal subcutaneous adipose tissue in patients with and without antiretroviral therapy-associated lipodystrophy.

Authors:  Ksenia Sevastianova; Jussi Sutinen; Dario Greco; Meline Sievers; Kaisa Salmenkivi; Julia Perttilä; Vesa M Olkkonen; Dick Wågsäter; Martin E Lidell; Sven Enerbäck; Per Eriksson; Ulrich A Walker; Petri Auvinen; Matti Ristola; Hannele Yki-Järvinen
Journal:  Diabetes       Date:  2011-05-20       Impact factor: 9.461

6.  Genetic and cytometric analyses of subcutaneous adipose tissue in patients with hemophilia and HIV-associated lipodystrophy.

Authors:  Takanobu Mashiko; Kunihisa Tsukada; Hitomi Takada; Szu-Hsien Wu; Koji Kanayama; Rintaro Asahi; Masanori Mori; Akira Kurisaki; Shinichi Oka; Kotaro Yoshimura
Journal:  AIDS Res Ther       Date:  2022-03-04       Impact factor: 2.250

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.